1 Min Read
Feb 28 (Reuters) - Akorn Inc:
* Akorn receives approval for mycophenolate mofetil for injection, USP Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.